Von Hippel-Lindau Disease Explore

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Meet Our Experts

PracticeUpdate is guided by a world-renowned Editorial and Advisory Board that represents community practitioners and academic specialists with cross-disciplinary expertise. View all boards

Cardiology

Douglas Zipes MD
Editor in Chief

Clinical Dentistry

Michael Newman DDS, FACD
Editor in Chief

Dermatology

Robert Brodell MD, FAAD
Editor in Chief

Diabetes

Silvio Inzucchi MD
Editor in Chief

Eye Care

Paul Freeman OD, FAAO, FCOVD
Editor in Chief

Eye Care

Myron Yanoff MD
Editor in Chief

Gastroenterology

Gail Hecht MD
Editor in Chief

Neurology

Mark Hallett MD
Editor in Chief

Oncology

Rafael Fonseca MD
Editor in Chief

Primary Care

David Rakel MD, FAAFP
Editor in Chief

Respiratory Medicine

Shyoko Honiden MD, MSc
Editor in Chief

Von Hippel-Lindau Disease

Editor's Picks

Inter- and Intra-Tumor Heterogeneity of Genetic and Immune Profiles in Inherited Renal Cell Carcinoma

Supratentorial Collision Tumor of Hemangioblastoma and Metastatic Clear Cell Renal Cell Carcinoma in a Patient With von Hippel–Lindau Disease

2023 Top Story in von Hippel–Lindau Disease: Guidelines for the Surveillance of Patients With von Hippel–Lindau Disease

68Ga-DOTANOC PET/CT for Screening for and Surveillance of von Hippel–Lindau Disease

Outcomes of and Indications for Renal Transplantation in Patients With von Hippel–Lindau Disease

Guidelines for the Surveillance of Patients With von Hippel–Lindau Disease

Expert Opinion

2023 Top Story in von Hippel–Lindau Disease: Guidelines for the Surveillance of Patients With von Hippel–Lindau Disease

ASCO 2023: Abstract Recommendations From Dr. Amit Tirosh for von Hippel–Lindau Disease

ASCO 2022: Abstract Recommendation From Dr. Amit Tirosh for Von Hippel-Lindau Disease

Healthcare Resource Utilization and Costs Among Patients With VHL-Associated RCC

Von Hippel-Lindau Disease Cases

Belzutifan in VHL Syndrome

Papillomacular Bundle Hemangioblastoma in a 19-Year-Old Woman With VHL

Planning Forward—Young Man, Newly Diagnosed With Full-blown VHL and His Younger Relatives Awaiting Surveillance Planning—How Would You Proceed?

Clinical Manifestations of Heterozygote Carrier With Rare VHL Gene Variant Responsible for Congenital Erythrocytosis

VHL Patient With Pancreatic Lesions

Journal Scans

Using the Kidney Imaging Surveillance Scoring System to Predict the Growth Rate of Renal Tumors in Patients With von Hippel–Lindau Syndrome

New Prospects on Neuroimaging in von Hippel–Lindau Disease

pVHL Forms Fibrillar Amyloid Assemblies That Are Mitigated by Purpurin

Hemangioblastomas and Other Vascular-Originating Tumors of the Brain or Spinal Cord

Inter- and Intra-Tumor Heterogeneity of Genetic and Immune Profiles in Inherited Renal Cell Carcinoma

von Hippel–Lindau Syndrome and Steroid Cell Tumor of the Ovary

von Hippel–Lindau Disease–Related Neoplasia With an Emphasis on Renal Manifestations

Supratentorial Collision Tumor of Hemangioblastoma and Metastatic Clear Cell Renal Cell Carcinoma in a Patient With von Hippel–Lindau Disease

68Ga-DOTANOC PET/CT for Screening for and Surveillance of von Hippel–Lindau Disease

News

FDA Approves Belzutifan for Cancers Associated With von Hippel-Lindau Disease

Oops! We have no items to display.

Meet Our Experts

Recently Updated